Wright L. Lassiter's most recent trade in Quest Diagnostics, Inc. was a trade of 7 Common Stock done at an average price of $167.6 . Disclosure was reported to the exchange on July 21, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quest Diagnostics | Wright L. Lassiter | Director | 21 Jul 2025 | 7 | 9,044 (0%) | 0% | 167.6 | 1,173 | Common Stock | |
| Quest Diagnostics | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2025 | 160 | 520 | - | - | Phantom Stock Units | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 2,140 | 2,140 | - | - | Director Stock Option (Right to Buy) | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 2,120 | 14,494 (0%) | 0% | 0 | Common Stock | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 70.87 per share. | 02 Jun 2025 | 1,625 | 16,119 (0%) | 0% | 70.9 | 115,164 | Common Stock |
| Quest Diagnostics | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 1,203 | 9,037 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 169 | 359 | - | - | Phantom Stock Units | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 91.50 per share. | 27 Mar 2025 | 2 | 12,374 (0%) | 0% | 91.5 | 183 | Common Stock |
| Quest Diagnostics | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 190 | 190 | - | - | Phantom Stock Units | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 91.50 per share. | 26 Dec 2024 | 2 | 12,372 (0%) | 0% | 91.5 | 183 | Common Stock |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 1,990 | 1,990 | - | - | Director Stock Option (Right to Buy) | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 1,970 | 10,855 (0%) | 0% | 0 | Common Stock | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 76.14 per share. | 03 Jun 2024 | 1,515 | 12,370 (0%) | 0% | 76.1 | 115,352 | Common Stock |
| Quest Diagnostics | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 1,482 | 7,709 (0%) | 0% | 0 | Common Stock | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 2,310 | 2,310 | - | - | Director Stock Option (Right to Buy) | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 2,290 | 7,130 (0%) | 0% | 0 | Common Stock | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 65.60 per share. | 06 Jun 2023 | 1,755 | 8,885 (0%) | 0% | 65.6 | 115,128 | Common Stock |
| Quest Diagnostics | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 1,369 | 6,092 (0%) | 0% | 0 | Common Stock | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 4,570 | 4,570 | - | - | Director Stock Option (Right to Buy) | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 59.74 per share. | 06 Jun 2022 | 1,930 | 4,840 (0%) | 0% | 59.7 | 115,298 | Common Stock |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 1,510 | 2,910 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2022 | 1,292 | 4,633 (0%) | 0% | 0 | Common Stock | |
| DT Midstream Inc | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 1,795 | 1,795 | - | - | Restricted Stock Units | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 1,860 | 1,860 | - | - | Employee Stock Option (Right to Buy) | |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 73.43 per share. | 24 Jan 2022 | 785 | 1,400 (0%) | 0% | 73.4 | 57,643 | Common Stock |
| Fortive | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 615 | 615 (0%) | 0% | 0 | Common Stock | |
| DT Midstream Inc | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Aug 2021 | 2,417 | 2,417 | - | - | Restricted Stock Units | |
| Quest Diagnostics | Wright L. Lassiter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 1,363 | 3,281 (0%) | 0% | 0 | Common Stock |